Predicting Tumor Regrowth in Patients Undergoing Non-Operative Management after Total Neoadjuvant Therapy
This study did not identify any predictors of tumor regrowth in patients undergoing NOM after TNT. The limited number of events severely restricted the power to detect statistically meaningful associations. Nevertheless, this area warrants further investigation to better tailor surveillance strategies and optimize NOM recommendations.
Authors
- Satish E. Viswanath (ORCID: https://orcid.org/0000-0003-4550-8337)
- Kamil Erözkan (ORCID: https://orcid.org/0000-0003-2193-9984)
- Lauren E. Henke (ORCID: https://orcid.org/0000-0003-2208-3241)
- Meagan Costedio (ORCID: https://orcid.org/0000-0001-6825-0514)
- J. Eva Selfridge (ORCID: https://orcid.org/0000-0001-8979-1416)
- Emily Simon (ORCID: https://orcid.org/0000-0003-0873-8336)
- Ronald Charles (ORCID: https://orcid.org/0000-0002-0196-443X)
- Emily F. Steinhagen (ORCID: https://orcid.org/0000-0002-1155-6624)
Institutions
- University Hospitals of Cleveland (US)
- University Hospitals Cleveland Medical Center (US)
- Think A Move (United States) (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Journal of Gastrointestinal Cancer
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1007/s12029-025-01342-5
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Defense
- National Institutes of Health
- National Cancer Institute